Literature DB >> 29368453

The role of HLA-G in parasitic diseases.

A Sabbagh1, P Sonon2, I Sadissou2, C T Mendes-Junior3, A Garcia1,4, E A Donadi2, D Courtin1.   

Abstract

Little attention has been devoted to the role of HLA-G gene and molecule on parasitic disorders, and the available studies have focused on malaria, African and American trypanosomiasis, leishmaniosis, toxoplasmosis and echinococcosis. After reporting a brief description regarding the role of the cells of innate and adaptive immune system against parasites, we reviewed the major features of the HLA-G gene and molecule and the role of HLA-G on the major cells of immune system. Increased levels of soluble HLA-G (sHLA-G) have been observed in patients presenting toxoplasmosis and in the active phase of echinococcosis. In addition, increased sHLA-G has also been associated with increased susceptibility to malaria and increased susceptibility to develop human African trypanosomiasis (HAT). In contrast, decreased membrane-bound HLA-G has been reported in placenta of patients infected with Plasmodium falciparum and in heart and colon of patients presenting Chagas disease. The 3' untranslated region of the HLA-G gene has been the main focus of studies on malaria, HAT and Chagas disease, exhibiting distinct patterns of associations. Considering that HLA-G is an immune checkpoint molecule, inhibiting the activity of several cells of the immune system, the excessive neoexpression and the increased sHLA-G levels together with the decreased constitutive tissue expression of membrane-bound HLA-G may be detrimental to the host infected with parasite agents.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HLA-G; echinococcosis; genetics; immune system; leishmaniosis; malaria; parasite; toxoplasmosis; trypanosomiasis

Mesh:

Substances:

Year:  2018        PMID: 29368453     DOI: 10.1111/tan.13196

Source DB:  PubMed          Journal:  HLA        ISSN: 2059-2302            Impact factor:   4.513


  7 in total

1.  High level of soluble human leukocyte antigen (HLA)-G at beginning of pregnancy as predictor of risk of malaria during infancy.

Authors:  Tania C d'Almeida; Ibrahim Sadissou; Mermoz Sagbohan; Jacqueline Milet; Euripide Avokpaho; Laure Gineau; Audrey Sabbagh; Kabirou Moutairou; Eduardo A Donadi; Benoit Favier; Cédric Pennetier; Thierry Baldet; Nicolas Moiroux; Edgardo Carosella; Philippe Moreau; Nathalie Rouas-Freiss; Gilles Cottrell; David Courtin; André Garcia
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

2.  Fetal HLA-G mediated immune tolerance and interferon response in preeclampsia.

Authors:  Satu Wedenoja; Masahito Yoshihara; Hindrek Teder; Hannu Sariola; Mika Gissler; Shintaro Katayama; Juho Wedenoja; Inka M Häkkinen; Sini Ezer; Nina Linder; Johan Lundin; Tiina Skoog; Ellika Sahlin; Erik Iwarsson; Karin Pettersson; Eero Kajantie; Mikael Mokkonen; Seppo Heinonen; Hannele Laivuori; Kaarel Krjutškov; Juha Kere
Journal:  EBioMedicine       Date:  2020-07-14       Impact factor: 8.143

Review 3.  COVID-19: Integrating the Complexity of Systemic and Pulmonary Immunopathology to Identify Biomarkers for Different Outcomes.

Authors:  Thais Fernanda de Campos Fraga-Silva; Sandra Regina Maruyama; Carlos Arterio Sorgi; Elisa Maria de Sousa Russo; Ana Paula Morais Fernandes; Cristina Ribeiro de Barros Cardoso; Lucia Helena Faccioli; Marcelo Dias-Baruffi; Vânia Luiza Deperon Bonato
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

4.  HLA-G genetic diversity and evolutive aspects in worldwide populations.

Authors:  Erick C Castelli; Bibiana S de Almeida; Yara C N Muniz; Nayane S B Silva; Marília R S Passos; Andreia S Souza; Abigail E Page; Mark Dyble; Daniel Smith; Gabriela Aguileta; Jaume Bertranpetit; Andrea B Migliano; Yeda A O Duarte; Marília O Scliar; Jaqueline Wang; Maria Rita Passos-Bueno; Michel S Naslavsky; Mayana Zatz; Celso Teixeira Mendes-Junior; Eduardo A Donadi
Journal:  Sci Rep       Date:  2021-11-29       Impact factor: 4.379

5.  Immunomodulatory Potential of Non-Classical HLA-G in Infections including COVID-19 and Parasitic Diseases.

Authors:  Sajad Rashidi; Carmen Vieira; Renu Tuteja; Reza Mansouri; Mohammad Ali-Hassanzadeh; Antonio Muro; Paul Nguewa; Raúl Manzano-Román
Journal:  Biomolecules       Date:  2022-02-04

6.  Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.

Authors:  Ismael Chatita Adolf; Gokce Akan; Teddy F Mselle; Nazima Dharsee; Lucy A Namkinga; Fatmahan Atalar
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01

Review 7.  Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E.

Authors:  Inès Zidi
Journal:  Hum Immunol       Date:  2020-10-07       Impact factor: 2.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.